Overview
Vilas Nasare practices practicing medicine in Kolkata, India.
His clinical expertise encompasses Ovarian Cancer, Breast Cancer, Stomach Cancer, and Triple-Negative Breast Cancer.
He is actively involved in clinical research, co-authoring 26 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Vilas D. Nasare
Is Vilas D. Nasare a top-rated expert for Ovarian Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Vilas D. Nasare is classified as an Experienced expert for Ovarian Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Vilas D. Nasare participate in research or clinical trials?
Yes. Vilas D. Nasare has published 26 articles and abstracts on conditions like Ovarian Cancer. You can view a list of Vilas D. Nasare's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerMr. Nasare isExperienced. Learn about Breast Cancer.
- Ovarian CancerMr. Nasare isExperienced. Learn about Ovarian Cancer.
- Stomach CancerMr. Nasare isExperienced. Learn about Stomach Cancer.
- Triple-Negative Breast CancerMr. Nasare isExperienced. Learn about Triple-Negative Breast Cancer.